180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

December 4, 2024 8:00 AM

PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced the appointment of Stephen Shoemaker to its Board of Directors, effective December 3, 2024.Mr. Shoemaker brings to 180 a wealth of experience as a seasoned senior executive and board member with a...

Read more

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

December 4, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced that Water Tower Research has issued a report highlighting Ainos' strategic partnership with Taiwan Tanabe Seiyaku for manufacturing and marketing VELDONA®, a novel therapeutic...

Read more

Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania

December 4, 2024 8:00 AM

VANCOUVER, BC / ACCESSWIRE / December 4, 2024 / (CSE:OVAT)(OTC PINK:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its proprietary skin delivery technology Invisicare®, announces the official launch of its products in Pennsylvania through its licensee: PA Options for Wellness Inc. ("PA Options").The launch marks Ovation's second licensee in the USA and is part of...

Read more

Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

December 4, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced the initiation of a strategic partnership with a leading specialty drug manufacturer for the development and commercial launch of PF614 and PF614-MPAR drug...

Read more

Respiratory Health Technologies Partners with Boomerang Studio for the Launch of SinuSauna(TM): A Revolutionary Innovation in Respiratory Wellness

December 4, 2024 7:30 AM

Respiratory Health Technologies (RHT), an emerging leader in respiratory wellness, has launched its first product, the SinuSauna™, through a transformative partnership with Indy-based Boomerang Studio. SinuSauna is the first product to use heated dry air therapy to potentially prevent congestion without the need for medications and nasal irrigation. RHT was selected by Boomerang Studio, the studio arm of Boomerang Ventures, which specializes in...

Read more

BioSpherix Boosts Product Visibility and Sales Conversion With Bioz Badges and a Bioz Content Hub

December 4, 2024 4:00 AM

Bioz, Inc., a leader in AI-powered citation tracking and product engagement, is thrilled to announce its partnership with BioSpherix, a manufacturer of advanced Cytocentric® controllers, chambers, and systems. BioSpherix has been utilizing Bioz Badges and a Bioz Content Hub to enhance both their sales and marketing initiatives, resulting in significant improvements in user engagement and sales conversion.Bioz Pro BadgeBioz Pro Badge on the...

Read more

Aytu BioPharma Disclosure Notification

December 3, 2024 11:45 PM

DENVER, CO / ACCESSWIRE / December 3, 2024 / SUMMARY NOTICE OF PENDENCY OF DERIVATIVE ACTION, AGREEMENT OF SETTLEMENT AND RELEASE WITH RESPECT TO CERTAIN PARTIES, AND SETTLEMENT HEARING IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE LITIGATION STYLED WITMER V. ARMISTICE CAPITAL LLC, ET AL., NO. 2022-0807-MTZ (THE "ACTION").TO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF AYTU BIOPHARMA, INC. ("AYTU" OR THE "COMPANY")...

Read more

Liom Cracks "Holy Grail" of Non-Invasive Glucose Monitoring and Secures USD >25m in Funding Kickstarting Its Series A

December 3, 2024 5:15 PM

Liom has continued its technological progress: it is the first and only company to demonstrate accurate non-invasive glucose measurements without the need for invasive per-subject calibration using a needle. This puts Liom ahead of the deep-pocketed, established players in the wearable business, such as Apple, Samsung and Google, that so far were not able to share comparable results. Liom has repeatedly demonstrated this capability throughout...

Read more

Ensysce Biosciences Announces 1-for-15 Reverse Stock Split

December 3, 2024 4:15 PM

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on Friday, December 6, 2024, effective at 12:01 a.m. Eastern Time, it will implement a 1-for-15 reverse split of its common stock. The Company's common...

Read more

Mayan Languages Preservation and Digitization Project Expands Digital Access With New Universal Mayan, Q’eqchi', and K'iche’ Keyboards for Android

December 3, 2024 12:10 PM

The Mayan Languages Preservation and Digitization Project proudly announces the launch of the Universal Mayan, Q'eqchi', and K'iche' Keyboards for Android devices. These innovative tools, designed from the ground up, mark significant progress in the ongoing efforts to preserve and expand digital access for Mayan language speakers, providing essential resources that empower millions of users across North and Central America who primarily connect...

Read more

CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy

December 3, 2024 11:45 AM

CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is steadily advancing its position in high-efficiency cannabis production. The Company is excited to share its latest updates with shareholders and prospective investors, highlighting its substantial progress, current operations, and future growth plans.Advanced Production Facility in AlbertaCannaPharmaRX's advanced facility in Alberta houses 10 growing rooms designed...

Read more

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

December 3, 2024 11:00 AM

WOBURN, MA / ACCESSWIRE / December 3, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.The conference...

Read more

Jorie AI Achieves HITRUST R2 Certification Demonstrating the Highest Level of Information Protection Assurance

December 3, 2024 11:00 AM

Jorie AI, a leading provider of AI-driven solutions for healthcare revenue cycle management, today announced that its systems have earned certified status by HITRUST for information security.HITRUST r2 Certification demonstrates that Jorie AI's Revenue Cycle Management platform has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places Jorie AI in an elite group of...

Read more

Enable Me Finds Improved Clinic Workflow, Patient Safety and Help with Staff Shortages are Among the Benefits of the Clinically Designed VELA Mammography Chair, Per an Informal Survey of Clinicians

December 3, 2024 10:15 AM

Enable Me, a VELA Medical Company, today reported informal survey findings that conclude the use of the clinically-designed VELA Mammography Chair can improve clinic workflow and provide health benefits for technologists while reducing stress and discomfort for patients. CHIEF FINANCIAL OFFICERS WILL SEE BENEFITS OF THIS BUSINESS ASSET"Chief financial officers and clinic managers will appreciate the improved workflow achieved when elderly,...

Read more

Ascend Aesthetic Partners Marks First Year Uniting Top Surgeons in Aesthetic Care Nationwide

December 3, 2024 10:00 AM

Ascend Aesthetic Partners marks one year of uniting premier plastic surgeons, aesthetic providers, and care teams from across the country, reaffirming its commitment to advancing the field of aesthetic medicine. Since its launch, Ascend has expanded significantly and continues to focus on building a collaborative community as it moves into 2025."In the span of one year, Ascend Aesthetic Partners has built a robust network of 18 plastic surgeons,...

Read more

Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

December 3, 2024 9:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced that it has successfully completed enrollment in its pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) study of DMT310, a novel, once-weekly, topical product candidate for...

Read more

Liver Transplant Market Poised for Significant Growth, projected to Reach USD 2,653.4 Million by 2033 At A 6.5% CAGR, driven by Rising Demand and Advancements in Machine Perfusion Technology | Future Market Insights, Inc.

December 3, 2024 9:00 AM

The Liver Transplantation Market 2023 to 2033 is witnessing significant growth, reflecting advancements in medical technology and rising prevalence of liver-related diseases. In 2023, the market is valued at USD 1,409.8 million and is projected to reach USD 2,653.4 million by 2033, marking a robust CAGR of 6.5% over the forecast period.The increasing incidence of liver disorders such as cirrhosis and hepatocellular carcinoma is a major driver....

Read more

Healing Hands: The Story of Dr. Ranen and His Chiropractic Sport Experience

December 3, 2024 8:30 AM

Dr. Ranen Rambrij stands out as a leading figure in chiropractic care for athletes. Renowned for his skills in diagnosing, treating and managing athletes, he has established himself as a top-tier Chiropractor. He expertly merges knowledge, precision, and an intense passion for Chiropractic that enable athletes to achieve their optimal performance.Who is Dr. Ranen?His journey in Chiropractic started in 2006 after experiencing an Injury while...

Read more

CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s

December 3, 2024 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), a leader in cannabinoid innovation, proudly announces the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions.CBD Life Sciences' entry into...

Read more

Modular Medical Announces Conference Call to Provide Business Update

December 3, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business...

Read more